|
|
 |
|
Viewing report
|
|
|
|
The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide
Research Facts Ltd, Oct 2009, Pages: 88
Inhaled therapies have been used since ancient times and may have had their origins with the smoking of datura preparations in India 4,000 years ago. Inhalation became a mainstay of respiratory care in the 20th century. Due to the nature of the absorption within the lungs, inhaled pharmaceuticals tend to be very fast acting. Inhalation usually provides a very fast rise of the level of the pharmaceutical in the blood, when compared to other delivery techniques, such as oral or transdermal delivery. For example, albuterol is a bronchodialator which acts rapidly when inhaled to treat an asthma attack, a condition for which treatment with a solid oral dosage form may be too slow. In fact, inhaled medication is the commonest form of therapy for acute and chronic asthma and for other conditions associated with airflow limitation (obstructive bronchitis, emphysema, cystic fibrosis).
There are many pharmaceutical companies worldwide. This report profiles the Top 40 developers of inhaled pharmaceuticals. These are the companies with the experience, know-how and resources that enable them to develop, manufacture and market innovative products that can compete effectively in global markets.
Profile information for each company in The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide typically includes:
- Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Address
- Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers
- Specialised fields such as Company Description, Ownership, Products, Therapeutic Areas, Foreign Trade, Location Status, Year Established, Number of Employees and Turnover.
Report Target Market:
1) Pharmaceutical Companies
Usage: competitive/financial analysis and strategic partner/alliance identification.
2) Drug Delivery Companies
This report is perfect for speciality drug delivery companies with inhalation drug delivery technologies and expertise.
3) Manufacturers Of Inhalation Devices
The Top 40 Developers Of Inhaled Pharmaceuticals Worldwide is ideal for manufacturers of inhalation devices such as metered-dose inhalers to identify new potential customers.
4) Contract Services Providers
This report is very useful to contract services providers for pharmaceutical, biotechnology and medical device companies that bring new inhalation products to market.
Note: Most people will be aware of some of the major developers of inhaled pharmaceuticals such as AstraZeneca PLC, but this report looks at all 40 of the top companies - companies like - Dey, L.P. - a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, respiratory-related allergies, and emergency care medicine and the U.S. leader in sales of nebulized respiratory medication.
Report data field structure is as follows:
Company Name
Mailing Address
Street Address
Telephone
Fax
Email
Website
Parent Company Name
Year Established
Number of Employees
Key Executives
Company Description
Products
Therapeutic Areas
Turnover €m
Foreign Trade
Location Status
Ownership
Research Facts is a world leader in life sciences publishing. It was established in Dublin, Ireland in 2004. Its partners have over forty years combined experience in the business information industry. Research Facts’ customers include most of the world’s major diagnostics, pharmaceutical, biotechnology and medical device companies e.g. Roche, Abbott, Quintiles, Johnson & Johnson, Wyeth, GlaxoSmithKline, Medtronic, Siemens Medical, Philips Healthcare, Thermo Fisher Scientific, GE Healthcare, Ipsen, Edwards Lifesciences etc..
Research Facts’ reports help you make informed decisions about the markets and organisations that affect your business.
- Learn more about your target markets and target companies
- Top level research on all major players in a market
- See which organisations dominate your major markets
- Get detailed information on particular organisations
Formats:
Hardcopy: Bound report, A4 format, 88 pages
Electronic: pdf Version, A4 format, 88 pages
Author: The scientific advisor on this report was Katie Ryan. Katie has degrees in physiology and medicine from Trinity College Dublin and is a full-time researcher there in the School of Medicine.
Keywords:
Inhaled Pharmaceuticals
Customers who bought this item also bought
Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition
The Top 100 Contract Research Organisations In Europe
Inhaled Drug Delivery: Devices, Indications, Therapeutics, Markets and Forecasts
The Top 35 Central Nervous System Drug Delivery Technology Companies Worldwide
The Top 50 Oncology Contract Research Organisations In Europe
Delivering Opportunities in the Inhalable Drugs Market: Innovative formulations and devices
The Top 50 Transdermal Drug Delivery Technology Companies Worldwide
Chronic Obstructive Pulmonary Disease - Global Strategic Business Report
The Top 25 Contract Research Organisations In Germany & France
The Top 50 Contract Research Organisations In Europe For Cardiovascular Diseases & Disorders
|
|
|
|
